Predictors of Adverse Outcomes in Neonates with Seizures

Menna Ebrahim Hashish; Ahmad Darwish; Mohamed Reda Bassiouny

doi:doi:10.11648/j.ajp.20220803.12

| Peer-Reviewed

Predictors of Adverse Outcomes in Neonates with Seizures

Menna Ebrahim Hashish, Ahmad Darwish, Mohamed Reda Bassiouny

Published in American Journal of Pediatrics (Volume 8, Issue 3)

Received: 23 June 2022 Accepted: 9 July 2022 Published: 20 July 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Seizures in neonatal period could generate long-term neurodevelopmental impairment; therefore, explicit clarification of adverse outcome predictors should direct the ongoing and subsequent treatment plan. Objective: The study aimed to address predictors of adverse neurodevelopmental outcomes and/or mortality of full-term infants who developed neonatal seizures. Methods: This longitudinal prospective cohort study was conducted from 2019 to 2021 in tertiary hospital, Egypt and included the full-term infants till 18 months of age after occurrence of clinical/electrical seizures in neonatal period and healthy infants of matched age and sex. All infants were assessed by Bayley-III developmental scales in three main domains (cognitive, language and motor). The required data for the predictive factors of adverse outcome had been registered on REDCap tools and exported for statistical analysis. Results: Sixty four infants were enrolled (35 developed seizures and 29 were healthy), 29% died. There were significant group differences (better results were in favor of healthy infants) in the need for initial resuscitation, 1^st and 5^th minute APGAR score and in all developmental domains. Medium correlation was found between abnormal motor subscale and multiple attacks of seizures, the need for anti-seizure medication on discharge and low 5^th minute APGAR score. Time to death was significant earlier in infants required initial resuscitation, developed seizures within 1^st day of life with special characteristics (as exceeding 6 days with abnormal aEEG background, >2 anti-epileptic drugs were prescribed for optimum control and also were prescribed on their discharge plan) and also those exceeded 19 days admission in NICU. Conclusion: Occurrence of seizures in neonatal period had its unique signature on long-term morbidity. Early death and abnormal motor domain in later life could be predicted from the 1^st days of birth though low APGAR score, frequency and duration of seizures, EEG background and the need for anti-seizure medication on discharge.

Published in	American Journal of Pediatrics (Volume 8, Issue 3)
DOI	10.11648/j.ajp.20220803.12
Page(s)	158-167
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

APGAR Score, Cognitive, Language, Seizures

References

[1]	Kaminiów K, Kozak S, Paprocka JJC. (2021). Neonatal Seizures Revisited. 8 (2), 155.
[2]	Glass HC, Glidden D, Jeremy RJ, Barkovich AJ, Ferriero DM, Miller SP. (2009). Clinical Neonatal Seizures are Independently Associated with Outcome in Infants at Risk for Hypoxic-Ischemic Brain Injury. J Pediatr, 155 (3), 318-23.
[3]	Bari A, Pathan H, Kokiwar PJIJCP. (2017). Incidence and outcome of neonatal seizures at a tertiary care hospital. 4, 2165-9.
[4]	Uria-Avellanal C, Marlow N, Rennie JM. (2013). Outcome following neonatal seizures. Semin Fetal Neonatal Med, 18 (4), 224-32.
[5]	Kang SK, Kadam SDJfiP. (2015). Neonatal seizures: impact on neurodevelopmental outcomes. 3, 101.
[6]	Cornejo BJ, Mesches MH, Coultrap S, Browning MD, Benke TA. (2007). A single episode of neonatal seizures permanently alters glutamatergic synapses. Annals of neurology, 61 (5), 411-26.
[7]	Hintz SR, Newman JE, Vohr BR, editors. Changing definitions of long-term follow-up: should “long term” be even longer? Seminars in perinatology; 2016: Elsevier.
[8]	Bayley N. Bayley scales of infant and toddler development: Bayley-III: Harcourt Assessment, Psych. Corporation; 2006.
[9]	Hunt RW, Liley HG, Wagh D, Schembri R, Lee KJ, Shearman AD, et al. (2021). Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial. 4 (12), e2139604-e.
[10]	Maitre NL, Smolinsky C, Slaughter JC, Stark AR. (2013). Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. Journal of perinatology: official journal of the California Perinatal Association, 33 (11), 841-6.
[11]	Ghosh S, Cabassa Miskimen AC, Brady J, Robinson MA, Zou B, Weiss M, et al. (2019). Neurodevelopmental outcomes at 9-14 months gestational age after treatment of neonatal seizures due to brain injury. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery, 35 (9), 1571-8.
[12]	Arican P, Olgac Dundar N, Mete Atasever N, Akkaya Inal M, Gencpinar P, Cavusoglu D, et al. (2020). Comparison of the neurocognitive outcomes in term infants treated with levetiracetam and phenobarbital monotherapy for neonatal clinical seizures. Seizure, 80, 71-4.
[13]	Maartens IA, Wassenberg T, Buijs J, Bok L, de Kleine MJ, Katgert T, et al. (2012). Neurodevelopmental outcome in full-term newborns with refractory neonatal seizures. Acta paediatrica (Oslo, Norway: 1992), 101 (4), e173-8.
[14]	Lloyd R, Goulding R, Filan P, Boylan GJAp. (2015). Overcoming the practical challenges of electroencephalography for very preterm infants in the neonatal intensive care unit. 104 (2), 152-7.
[15]	Hellström-Westas L, De Vries LS, Rosén I. An atlas of amplitude-integrated EEGs in the newborn: CRC Press; 2008.
[16]	Bayley N. Bayley-III: Bayley Scales of infant and toddler development: Giunti OS; 2009.
[17]	Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JGJJobi. (2009). Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. 42 (2), 377-81.
[18]	Garfinkle J, Shevell MI. (2011). Predictors of outcome in term infants with neonatal seizures subsequent to intrapartum asphyxia. J Child Neurol, 26 (4), 453-9.
[19]	Lai YH, Ho CS, Chiu NC, Tseng CF, Huang YL. (2013). Prognostic factors of developmental outcome in neonatal seizures in term infants. Pediatrics and neonatology, 54 (3), 166-72.
[20]	Soltirovska-Salamon A, Neubauer D, Petrovcic A, Paro-Panjan D. (2014). Risk factors and scoring system as a prognostic tool for epilepsy after neonatal seizures. Pediatr Neurol, 50 (1), 77-84.
[21]	Sankar R, Rho JM. (2007). Do seizures affect the developing brain? Lessons from the laboratory. J Child Neurol, 22 (5 Suppl), 21s-9s.
[22]	Pisani F, Spagnoli C. (2016). Neonatal Seizures: A Review of Outcomes and Outcome Predictors. Neuropediatrics, 47 (1), 12-9.
[23]	Pisani F, Sisti L, Seri S. (2009). A scoring system for early prognostic assessment after neonatal seizures. Pediatrics, 124 (4), e580-7.
[24]	Hall DA, Wadwa RP, Goldenberg NA, Norris JM. (2006). Maternal risk factors for term neonatal seizures: population-based study in Colorado, 1989-2003. J Child Neurol, 21 (9), 795-8.
[25]	Glass HC, Pham TN, Danielsen B, Towner D, Glidden D, Wu YW. (2009). Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998-2002. J Pediatr, 154 (1), 24-8.e1.
[26]	Nagarajan L, Palumbo L, Ghosh S. (2012). Classification of clinical semiology in epileptic seizures in neonates. Eur J Paediatr Neurol, 16 (2), 118-25.
[27]	Wusthoff CJ, Sundaram V, Abend NS, Massey SL, Lemmon ME, Thomas C, et al. (2021). Seizure Control in Neonates Undergoing Screening vs Confirmatory EEG Monitoring.
[28]	Chalak LF, Pappas A, Tan S, Das A, Sánchez PJ, Laptook AR, et al. (2021). Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up: A Nested Multisite Cohort Study. 78 (12), 1484-93.
[29]	Pavel AM, Rennie JM, de Vries LS, Blennow M, Foran A, Shah DK, et al. (2021). Neonatal Seizure Management–Is the Timing of Treatment Critical?
[30]	Blume HK, Garrison MM, Christakis DA. (2009). Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals. J Child Neurol, 24 (2), 148-54.
[31]	Bartha AI, Shen J, Katz KH, Mischel RE, Yap KR, Ivacko JA, et al. (2007). Neonatal seizures: multicenter variability in current treatment practices. 37 (2), 85-90.
[32]	Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, et al. (2016). Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study. J Pediatr, 174, 98-103.e1.
[33]	Glass HCJCip. (2014). Neonatal seizures: advances in mechanisms and management. 41 (1), 177-90.
[34]	Vasudevan C, Levene M. (2013). Epidemiology and aetiology of neonatal seizures. Semin Fetal Neonatal Med, 18 (4), 185-91.
[35]	Soul JS, editor Acute symptomatic seizures in term neonates: Etiologies and treatments. Seminars in Fetal and Neonatal Medicine; 2018: Elsevier.
[36]	Pisani F, Spagnoli C, editors. Acute symptomatic neonatal seizures in preterm neonates: etiologies and treatments. Seminars in Fetal and Neonatal Medicine; 2018: Elsevier.
[37]	Oh A, Thurman DJ, Kim HJDM, Neurology C. (2019). Independent role of neonatal seizures in subsequent neurological outcomes: a population-based study. 61 (6), 661-6.
[38]	Santarone ME, Pietrafusa N, Fusco LJS. (2020). Neonatal seizures: When semiology points to etiology. 80, 161-5.
[39]	Ramantani G, Schmitt B, Plecko B, Pressler RM, Wohlrab G, Klebermass-Schrehof K, et al. (2019). Neonatal Seizures-Are We there Yet? Neuropediatrics, 50 (5), 280-93.
[40]	Ronen GM, Buckley D, Penney S, Streiner DL. (2007). Long-term prognosis in children with neonatal seizures: a population-based study. Neurology, 69 (19), 1816-22.
[41]	Tekgul H, Gauvreau K, Soul J, Murphy L, Robertson R, Stewart J, et al. (2006). The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics, 117 (4), 1270-80.
[42]	Jensen FEJCip. (2009). Neonatal seizures: an update on mechanisms and management. 36 (4), 881-900.
[43]	Al-Momen H, Muhammed MK, Alshaheen AAJTTJoEM. (2018). Neonatal seizures in Iraq: Cause and outcome. 246 (4), 245-9.
[44]	Clancy RR, Legido A. (1991). Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia, 32 (1), 69-76.
[45]	Garfinkle J, Shevell MI. (2011). Prognostic factors and development of a scoring system for outcome of neonatal seizures in term infants. Eur J Paediatr Neurol, 15 (3), 222-9.
[46]	Garcias Da Silva LF, Nunes ML, Da Costa JC. (2004). Risk factors for developing epilepsy after neonatal seizures. Pediatr Neurol, 30 (4), 271-7.
[47]	Pavlidis E, Spagnoli C, Pelosi A, Mazzotta S, Pisani F. (2015). Neonatal status epilepticus: differences between preterm and term newborns. Eur J Paediatr Neurol, 19 (3), 314-9.
[48]	Garfinkle J, Shevell MI. (2011). Cerebral palsy, developmental delay, and epilepsy after neonatal seizures. Pediatr Neurol, 44 (2), 88-96.
[49]	Pisani F, Piccolo B, Cantalupo G, Copioli C, Fusco C, Pelosi A, et al. (2012). Neonatal seizures and postneonatal epilepsy: a 7-y follow-up study. Pediatr Res, 72 (2), 186-93.
[50]	Pisani F, Facini C, Pelosi A, Mazzotta S, Spagnoli C, Pavlidis E. (2016). Neonatal seizures in preterm newborns: A predictive model for outcome. Eur J Paediatr Neurol, 20 (2), 243-51.
[51]	Pavlidis E, Spagnoli C, Pelosi A, Mazzotta S, Pisani FJejopn. (2015). Neonatal status epilepticus: differences between preterm and term newborns. 19 (3), 314-9.
[52]	Pisani F, Cerminara C, Fusco C, Sisti L. (2007). Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology, 69 (23), 2177-85.
[53]	Natarajan G, Shankaran S, Laptook AR, McDonald SA, Pappas A, Hintz SR, et al. (2018). Association between sedation-analgesia and neurodevelopment outcomes in neonatal hypoxic-ischemic encephalopathy. Journal of perinatology: official journal of the California Perinatal Association, 38 (8), 1060-7.
[54]	Pellegrin S, Munoz FM, Padula M, Heath PT, Meller L, Top K, et al. (2019). Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. 37 (52), 7596.
[55]	Glass HC, Grinspan ZM, Shellhaas RA, editors. Outcomes after acute symptomatic seizures in neonates. Seminars in Fetal and Neonatal Medicine; 2018: Elsevier.

Cite This Article

Plain Text BibTeX RIS

APA Style

Menna Ebrahim Hashish, Ahmad Darwish, Mohamed Reda Bassiouny. (2022). Predictors of Adverse Outcomes in Neonates with Seizures. American Journal of Pediatrics, 8(3), 158-167. https://doi.org/10.11648/j.ajp.20220803.12

Copy | Download

ACS Style

Menna Ebrahim Hashish; Ahmad Darwish; Mohamed Reda Bassiouny. Predictors of Adverse Outcomes in Neonates with Seizures. Am. J. Pediatr. 2022, 8(3), 158-167. doi: 10.11648/j.ajp.20220803.12

Copy | Download

AMA Style

Menna Ebrahim Hashish, Ahmad Darwish, Mohamed Reda Bassiouny. Predictors of Adverse Outcomes in Neonates with Seizures. Am J Pediatr. 2022;8(3):158-167. doi: 10.11648/j.ajp.20220803.12

Copy | Download

@article{10.11648/j.ajp.20220803.12,
  author = {Menna Ebrahim Hashish and Ahmad Darwish and Mohamed Reda Bassiouny},
  title = {Predictors of Adverse Outcomes in Neonates with Seizures},
  journal = {American Journal of Pediatrics},
  volume = {8},
  number = {3},
  pages = {158-167},
  doi = {10.11648/j.ajp.20220803.12},
  url = {https://doi.org/10.11648/j.ajp.20220803.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20220803.12},
  abstract = {Background: Seizures in neonatal period could generate long-term neurodevelopmental impairment; therefore, explicit clarification of adverse outcome predictors should direct the ongoing and subsequent treatment plan. Objective: The study aimed to address predictors of adverse neurodevelopmental outcomes and/or mortality of full-term infants who developed neonatal seizures. Methods: This longitudinal prospective cohort study was conducted from 2019 to 2021 in tertiary hospital, Egypt and included the full-term infants till 18 months of age after occurrence of clinical/electrical seizures in neonatal period and healthy infants of matched age and sex. All infants were assessed by Bayley-III developmental scales in three main domains (cognitive, language and motor). The required data for the predictive factors of adverse outcome had been registered on REDCap tools and exported for statistical analysis. Results: Sixty four infants were enrolled (35 developed seizures and 29 were healthy), 29% died. There were significant group differences (better results were in favor of healthy infants) in the need for initial resuscitation, 1st and 5th minute APGAR score and in all developmental domains. Medium correlation was found between abnormal motor subscale and multiple attacks of seizures, the need for anti-seizure medication on discharge and low 5th minute APGAR score. Time to death was significant earlier in infants required initial resuscitation, developed seizures within 1st day of life with special characteristics (as exceeding 6 days with abnormal aEEG background, >2 anti-epileptic drugs were prescribed for optimum control and also were prescribed on their discharge plan) and also those exceeded 19 days admission in NICU. Conclusion: Occurrence of seizures in neonatal period had its unique signature on long-term morbidity. Early death and abnormal motor domain in later life could be predicted from the 1st days of birth though low APGAR score, frequency and duration of seizures, EEG background and the need for anti-seizure medication on discharge.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Predictors of Adverse Outcomes in Neonates with Seizures
AU  - Menna Ebrahim Hashish
AU  - Ahmad Darwish
AU  - Mohamed Reda Bassiouny
Y1  - 2022/07/20
PY  - 2022
N1  - https://doi.org/10.11648/j.ajp.20220803.12
DO  - 10.11648/j.ajp.20220803.12
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 158
EP  - 167
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20220803.12
AB  - Background: Seizures in neonatal period could generate long-term neurodevelopmental impairment; therefore, explicit clarification of adverse outcome predictors should direct the ongoing and subsequent treatment plan. Objective: The study aimed to address predictors of adverse neurodevelopmental outcomes and/or mortality of full-term infants who developed neonatal seizures. Methods: This longitudinal prospective cohort study was conducted from 2019 to 2021 in tertiary hospital, Egypt and included the full-term infants till 18 months of age after occurrence of clinical/electrical seizures in neonatal period and healthy infants of matched age and sex. All infants were assessed by Bayley-III developmental scales in three main domains (cognitive, language and motor). The required data for the predictive factors of adverse outcome had been registered on REDCap tools and exported for statistical analysis. Results: Sixty four infants were enrolled (35 developed seizures and 29 were healthy), 29% died. There were significant group differences (better results were in favor of healthy infants) in the need for initial resuscitation, 1st and 5th minute APGAR score and in all developmental domains. Medium correlation was found between abnormal motor subscale and multiple attacks of seizures, the need for anti-seizure medication on discharge and low 5th minute APGAR score. Time to death was significant earlier in infants required initial resuscitation, developed seizures within 1st day of life with special characteristics (as exceeding 6 days with abnormal aEEG background, >2 anti-epileptic drugs were prescribed for optimum control and also were prescribed on their discharge plan) and also those exceeded 19 days admission in NICU. Conclusion: Occurrence of seizures in neonatal period had its unique signature on long-term morbidity. Early death and abnormal motor domain in later life could be predicted from the 1st days of birth though low APGAR score, frequency and duration of seizures, EEG background and the need for anti-seizure medication on discharge.
VL  - 8
IS  - 3
ER  -

Copy | Download

Author Information

Menna Ebrahim Hashish

Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Ahmad Darwish

Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Mohamed Reda Bassiouny

Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Menna Ebrahim Hashish, Ahmad Darwish, Mohamed Reda Bassiouny. (2022). Predictors of Adverse Outcomes in Neonates with Seizures. American Journal of Pediatrics, 8(3), 158-167. https://doi.org/10.11648/j.ajp.20220803.12

Copy | Download

ACS Style

Menna Ebrahim Hashish; Ahmad Darwish; Mohamed Reda Bassiouny. Predictors of Adverse Outcomes in Neonates with Seizures. Am. J. Pediatr. 2022, 8(3), 158-167. doi: 10.11648/j.ajp.20220803.12

Copy | Download

AMA Style

Menna Ebrahim Hashish, Ahmad Darwish, Mohamed Reda Bassiouny. Predictors of Adverse Outcomes in Neonates with Seizures. Am J Pediatr. 2022;8(3):158-167. doi: 10.11648/j.ajp.20220803.12

Copy | Download

@article{10.11648/j.ajp.20220803.12,
  author = {Menna Ebrahim Hashish and Ahmad Darwish and Mohamed Reda Bassiouny},
  title = {Predictors of Adverse Outcomes in Neonates with Seizures},
  journal = {American Journal of Pediatrics},
  volume = {8},
  number = {3},
  pages = {158-167},
  doi = {10.11648/j.ajp.20220803.12},
  url = {https://doi.org/10.11648/j.ajp.20220803.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20220803.12},
  abstract = {Background: Seizures in neonatal period could generate long-term neurodevelopmental impairment; therefore, explicit clarification of adverse outcome predictors should direct the ongoing and subsequent treatment plan. Objective: The study aimed to address predictors of adverse neurodevelopmental outcomes and/or mortality of full-term infants who developed neonatal seizures. Methods: This longitudinal prospective cohort study was conducted from 2019 to 2021 in tertiary hospital, Egypt and included the full-term infants till 18 months of age after occurrence of clinical/electrical seizures in neonatal period and healthy infants of matched age and sex. All infants were assessed by Bayley-III developmental scales in three main domains (cognitive, language and motor). The required data for the predictive factors of adverse outcome had been registered on REDCap tools and exported for statistical analysis. Results: Sixty four infants were enrolled (35 developed seizures and 29 were healthy), 29% died. There were significant group differences (better results were in favor of healthy infants) in the need for initial resuscitation, 1st and 5th minute APGAR score and in all developmental domains. Medium correlation was found between abnormal motor subscale and multiple attacks of seizures, the need for anti-seizure medication on discharge and low 5th minute APGAR score. Time to death was significant earlier in infants required initial resuscitation, developed seizures within 1st day of life with special characteristics (as exceeding 6 days with abnormal aEEG background, >2 anti-epileptic drugs were prescribed for optimum control and also were prescribed on their discharge plan) and also those exceeded 19 days admission in NICU. Conclusion: Occurrence of seizures in neonatal period had its unique signature on long-term morbidity. Early death and abnormal motor domain in later life could be predicted from the 1st days of birth though low APGAR score, frequency and duration of seizures, EEG background and the need for anti-seizure medication on discharge.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Predictors of Adverse Outcomes in Neonates with Seizures
AU  - Menna Ebrahim Hashish
AU  - Ahmad Darwish
AU  - Mohamed Reda Bassiouny
Y1  - 2022/07/20
PY  - 2022
N1  - https://doi.org/10.11648/j.ajp.20220803.12
DO  - 10.11648/j.ajp.20220803.12
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 158
EP  - 167
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20220803.12
AB  - Background: Seizures in neonatal period could generate long-term neurodevelopmental impairment; therefore, explicit clarification of adverse outcome predictors should direct the ongoing and subsequent treatment plan. Objective: The study aimed to address predictors of adverse neurodevelopmental outcomes and/or mortality of full-term infants who developed neonatal seizures. Methods: This longitudinal prospective cohort study was conducted from 2019 to 2021 in tertiary hospital, Egypt and included the full-term infants till 18 months of age after occurrence of clinical/electrical seizures in neonatal period and healthy infants of matched age and sex. All infants were assessed by Bayley-III developmental scales in three main domains (cognitive, language and motor). The required data for the predictive factors of adverse outcome had been registered on REDCap tools and exported for statistical analysis. Results: Sixty four infants were enrolled (35 developed seizures and 29 were healthy), 29% died. There were significant group differences (better results were in favor of healthy infants) in the need for initial resuscitation, 1st and 5th minute APGAR score and in all developmental domains. Medium correlation was found between abnormal motor subscale and multiple attacks of seizures, the need for anti-seizure medication on discharge and low 5th minute APGAR score. Time to death was significant earlier in infants required initial resuscitation, developed seizures within 1st day of life with special characteristics (as exceeding 6 days with abnormal aEEG background, >2 anti-epileptic drugs were prescribed for optimum control and also were prescribed on their discharge plan) and also those exceeded 19 days admission in NICU. Conclusion: Occurrence of seizures in neonatal period had its unique signature on long-term morbidity. Early death and abnormal motor domain in later life could be predicted from the 1st days of birth though low APGAR score, frequency and duration of seizures, EEG background and the need for anti-seizure medication on discharge.
VL  - 8
IS  - 3
ER  -

Copy | Download